Showing results (31-40 of 137) with videos related to
Sort By:
Pageof 14
Pharmacoeconomics|May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness ModelsChase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 19, 2025
Return-on-Investment in Health Economic Evaluation: An Exploratory AnalysisMina Alizadehsadrdaneshpour, Jacob Smith, Mike Paulden, et al.BMC Health Services Research|November 20, 2014
A cost-utility analysis of a rehabilitation service for people living with and beyond cancerJeff Round, Baptiste Leurent, Louise JonesInternational Journal of Technology Assessment in Health Care|June 2, 2025
Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuumMegan Wiggins, Jeff Round, Erin KirwinMedical Decision Making : an International Journal of the Society for Medical Decision Making|April 8, 2024
Capturing Valuation Study Sampling Uncertainty in the Estimation of Health State Utility Values Using the EQ-5D-3LSpyridon Poulimenos, Jeff Round, Gianluca BaioAdvances in Experimental Medicine and Biology|September 9, 2010
Economic considerations in the provision of treatments for rare diseasesChristopher McCabe, Richard Edlin, Jeff RoundPalliative Medicine|July 23, 2015
Estimating the cost of caring for people with cancer at the end of life: A modelling studyJeff Round, Louise Jones, Steve MorrisQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2013
A framework for understanding quality of life in individuals without capacityJeff Round, Elizabeth L Sampson, Louise JonesPharmacoeconomics|November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit FrontierChristopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual ModelDaniel D H Howdon, James R S Lomas, Mike PauldenPageof 14